Thuja Capital BV - Company Review
Thuja Capital BV - Company ReviewSummary
Thuja Capital BV (Thuja Capital) is a financial services company that offers investments for early-stage medical products. The company offers life-science funds which include Thuja Capital Healthcare Fund II and Thuja Capital Healthcare Seed Fund II. Its Healthcare Fund II is a parent fund that invests in companies in the Benelux region. The company invests in medical companies operating in the fields of medical technology and devices; diagnostics, health monitoring technologies, therapeutics, medical food products and others. It offers support and financial services for companies in Belgium, the Netherlands and Luxemborg. Thuja Capital is headquartered in Utrecht, the Netherlands.
This comprehensive company report of Thuja Capital BV provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.